Abionyx Pharma SA (ABNX) — Cash Flow Reinvestment Rate
Latest as of December 2022:
0.27x
Abionyx Pharma SA (ABNX) has a Cash Flow Reinvestment Rate of 0.27x as of December 2022, reinvesting €57.00K (capex €57.00K ) from operating cash flow of €214.00K. See ABNX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.27x
(Capex + Investments) / Operating CF
Total Reinvested
€57.00K
Capex + Investments
Operating Cash Flow
€214.00K
EUR
Capital Expenditures
€57.00K
EUR
Annual Cash Flow Reinvestment Rate for Abionyx Pharma SA (None–None)
Year-by-year capital reinvestment analysis for Abionyx Pharma SA. See Abionyx Pharma SA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow